|

Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment

RECRUITINGSponsored by MiraKind
Actively Recruiting
SponsorMiraKind
Started2014-09
Est. completion2030-12
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT02253251

Summary

The investigators will recruit and enroll individuals that may have the KRAS-variant or other microRNA binding site mutations to join registry studies. The investigators will allow individuals to obtain their results through a physician at the completion of the studies. The investigators current focus is cancer and autoimmunity.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Personal or family history of cancer
* Personal history of endometriosis, or autoimmunity

Exclusion Criteria:

* Younger than 18
* Non-english speaking and unable to understand and sign the consent

Conditions2

Breast CancerCancer

Locations1 site

MiraKind
Los Angeles, California, 90025
Joanne Weidhaas, MDPhD203-671-1308joanne@mirakind.org

Find trials near these locations

Cancer trials in Los AngelesBreast Cancer trials in Los AngelesAll trials in California

Browse More Trials

Cancer trialsBreast Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.